Article

AAO LIVE: Researchers target risk factors for development of rhegmatogenous retinal detachments

Author(s):

In a presentation at the American Academy of Ophthalmology’s 2022 annual meeting in Chicago, William Kearney and Dan Gong, MD, discussed how patients with a unilateral retinal detachment frequently ask about the risk of developing an RRD in their fellow eye.

The American Academy of Ophthalmology is holding its 2022 annual meeting in Chicago. (Image courtesy of Adobe Stock)

The American Academy of Ophthalmology is holding its 2022 annual meeting in Chicago. (Image courtesy of Adobe Stock)

In a presentation at the American Academy of Ophthalmology’s 2022 annual meeting at McCormick Place in Chicago, William Kearney, MS, Dan Gong, MD, and colleagues from Massachusetts Eye and Ear, Harvard Medical School, Boston, identified risk factors for the development of rhegmatogenous retinal detachments (RRDs) in the fellow eye of patients who developed an RRD in one eye.

RRDs are sight-threatening conditions associated with potential morbidity, and patients with a unilateral retinal detachment frequently ask about the risk of developing an RRD in their fellow eye.

The investigators pointed out that this question is clinically relevant for Identifying fellow eyes with an increased risk of developing an RRD and may help improve the ability to diagnose RRDs earlier.

“This early diagnosis is essential since early repair increases the success rate of retinal reattachment surgery and improves visual outcomes,” Kearney said.

The investigators conducted a retrospective cohort study using the American Academy of Ophthalmology IRIS registry data from 2016 to 2020.

The study included 212,886 patients with a newly diagnosed RRD in one eye. The researchers collected data that included patient age, sex, race, geographic region, and smoking status.

The analysis found that 61.3% of patients were men (mean patient age, 60.7 years) who developed a new RRD in at least one eye.

A total of 6,826 (3.2%) developed an RRD in the fellow eye at a mean time of 406.5 days from the diagnosis of the RRD in the first eye, they reported.

Pars plana vitrectomy was the most common initial procedure (57.9%) performed to repair the RRD in the fellow eye, although 10.7% of patients required two or more procedures to reach that end.

Risk factors for fellow eye RRD

The risk factors for developing an RRD in the fellow eye were as follows: male versus female sex (hazard ratio [HR], 1.74; p < 0.001); younger age at first eye RRD diagnosis (HR 1.02, p < 0.001), Asian versus Caucasian ethnicity (HR, 0.54; p < 0.001); Black versus Caucasian race (HR, 0.55; p<0.001); active smoking status versus never smoked (HR, 1.12; p = 0.004); and Northeast versus Midwest residency (HR, 0.89; p = 0.007).

“In this cohort analysis of patients with a newly developed RRD in one eye, male sex, younger age of first eye RRD diagnosis, and active smoking were associated with higher risk of developing a fellow eye RRD,” investigators concluded.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.